Development of a prognostic model for overall survival in neuroblastoma based on Schwann cell-specific genes, clinical predictors, and MYCN amplification
This study developed a model for predicting OS in NBL by integrating Schwann cell-specific genes, clinical factors, and the TME. The model highlights the importance of specific cellular contributions to prognosis and provides a more personalized approach to NBL treatment, particularly for high-risk patients.
Authors
- Yingru Wu (ORCID: https://orcid.org/0000-0002-3714-6447)
- Ziru Li (ORCID: https://orcid.org/0000-0002-2755-9299)
- Jing Liu (ORCID: https://orcid.org/0000-0003-3467-9392)
Institutions
- Capital Institute of Pediatrics (CN)
- Children's Hospital of Capital Institute of Pediatrics (CN)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2025-05-01
- DOI
- https://doi.org/10.21037/tcr-24-2048
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00